Peer Review reports
From: Effect of alirocumab on cataracts in patients with acute coronary syndromes
| Original Submission | ||
|---|---|---|
| 25 Aug 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 27 Feb 2023 | Reviewed | Reviewer Report - Dov Gavish |
| 22 Mar 2023 | Reviewed | Reviewer Report - Aref Rahman |
| 17 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
| Resubmission - Version 4 | ||
| 17 Apr 2023 | Submitted | Manuscript version 4 |
| 18 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
| Resubmission - Version 5 | ||
| 18 Apr 2023 | Submitted | Manuscript version 5 |
| 25 Apr 2023 | Author responded | Author comments - Ph. Gabriel Steg |
| Resubmission - Version 6 | ||
| 25 Apr 2023 | Submitted | Manuscript version 6 |
| 1 May 2023 | Author responded | Author comments - Ph. Gabriel Steg |
| Resubmission - Version 7 | ||
| 1 May 2023 | Submitted | Manuscript version 7 |
| 4 May 2023 | Reviewed | Reviewer Report - Aref Rahman |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 2 Jun 2023 | Editorially accepted | |
| 16 Jun 2023 | Article published | 10.1186/s12886-023-03012-1 |
You can find further information about peer review here.